Corcept Therapeutics' ALS drug fails in mid-stage trial-March 2024-www.financetom.com

Corcept Therapeutics' ALS drug fails in mid-stage trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Corcept Therapeutics' ALS drug fails in mid-stage trial

Dec 11, 2024 1:49 PM

Dec 11 (Reuters) - Corcept Therapeutics ( CORT ) said on

Wednesday its experimental drug failed to meet the main goal of

a mid-stage trial in patients with amyotrophic lateral

sclerosis, a fatal neurodegenerative disease.

Previous page： McDonald's E. Coli Outbreak Expected to Have Minimal Impact Compared With Chipotle's 2016 Crisis, Wedbush Says Next page： CareDx, Dovetail Genomics Launch Partnership Focusing on Transplant Matching

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

McDonald's E. Coli Outbreak Expected to Have Minimal Impact Compared With Chipotle's 2016 Crisis, Wedbush Says

Oct 23, 2024

10:46 AM EDT, 10/23/2024 (MT Newswires) -- McDonald's (MCD) E. coli outbreak from Quarter Pounders is expected to have a much smaller impact than Chipotle Mexican Grill's ( CMG ) 2016 incident, Wedbush said in a report Wednesday. A report from the Centers for Disease Control and Prevention linked an E. coli outbreak to McDonald's Quarter Pounders, with 49 cases...

CareDx, Dovetail Genomics Launch Partnership Focusing on Transplant Matching

Oct 23, 2024

10:46 AM EDT, 10/23/2024 (MT Newswires) -- CareDx ( CDNA ) and Dovetail Genomics said Wednesday they are launching a partnership to back innovation projects in HLA genotyping for organ and stem cell transplant matching. The companies said HLA labs will be able to participate in an early access program that will use technologies from CareDx ( CDNA ) and...

UP Fintech Holding to Raise $90 Million From Sale of 15 Million American Depositary Shares

Oct 23, 2024

10:47 AM EDT, 10/23/2024 (MT Newswires) -- UP Fintech Holding ( TIGR ) said Wednesday it expects to raise $90 million from the sale of 15 million American depositary shares at $6.25 apiece in a public offering. Underwriters have a 20-day option to buy up to 2.25 million additional ADSs, the company said. The company expects to use net proceeds...

Viomi Technology Extends Share Repurchase Plan

Oct 23, 2024

10:46 AM EDT, 10/23/2024 (MT Newswires) -- Viomi Technology ( VIOT ) said Wednesday its board extended its share repurchase plan for another year, now running through Oct. 24, 2025. In October 2022, the board approved the buyback plan to repurchase up to $10 million of its American Depositary Shares through Oct. 24, 2024, Viomi ( VIOT ) said. The...